Archive for MHRA Updates
Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre-filled syringe EL (21)A/36
Source: MHRA Gov.uk Novartis Pharmaceuticals UK are recalling the above batch due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the...
Class 2 Medicines Recall: Intrapharm Laboratories Ltd, Mydrilate 0.5% Eye Drops 5ml, EL (21)A/35
Source: MHRA Gov.uk 8.12.21 Intrapharm Laboratories Ltd are recalling the above batch of Mydrilate 0.5 % Eye Drops 5ml as a precautionary measure due to out of specification results for...
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34
Source: MHRA Gov.uk 1/12/21 Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. MDR Number MDR...
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34
Source: MHRA Gov.uk 30.11.21 Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. MDR Number MDR...
Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd, EL (21)A/33
Source: MHRA Gov.uk 29.11.21 Error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd. MDR Number...
Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited, EL (21)A/32
Source: MHRA Gov.uk 29.11.21 Error with the patient information leaflet (PIL) that has been provided with Diuril Oral Solution, supplied by Mawdsley-Brooks & Company Limited. MDR Number MDR 241-11/21 Company...
Handpieces used in the phacoemulsification technique of cataract removal: need for careful cleaning (DSI/2021/009)
Source: MHRA / Govb.uk 24.11.21 Residue particles can end up in the patient’s eye. For the attention of decontamination specialists, theatre practitioners and anyone involved with the cleaning and decontamination...
Class 3 Medicines Recall: Martindale Pharma, an Ethypharm Group Company Methadone 5mg Tablets / Physeptone 5mg Tablets, EL (21)A/31
Source: MHRA/ Gov.uk 22.11.21 Martindale Pharma is recalling the below batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small...
Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) and parallel distributor, IKERVIS 1 mg/mL eye drops, emulsion and VERKAZIA 1 mg/mL eye drops, emulsion, EL (21)A/30
Source: MHRA Gov.uk 18/11/21 SANTEN Oy (trading as Santen UK Limited) are recalling the above batches of products as a precautionary measure due to detection of particles/crystals of the active...
Class 4 Medicines Defect Information: Slenyto 1 mg and 5mg prolonged-release tablets – distributed by Flynn Pharma Ltd, EL (21)A/29
Source: MHRA / Gov.uk Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets...
Investment and impact fund – inhaler prescribing
Source: NHSnetworks Four new indicators in the investment and impact fund (IIF) will support primary care teams in reducing carbon emissions from inhalers. Primary care networks (PCNs) are now rewarded...
Medicine Supply Notification: Xylocaine® 1% and 2% (lidocaine) with adrenaline 100micrograms/20ml solution for injection vials
Xylocaine® 1% and 2% (lidocaine) with adrenaline 100micrograms/20ml (1:200,000) solution for injection vials Tier 2 – medium impact* Date of issue: 8/11/2021 Link: https://www.sps.nhs.uk/shortages/shortage-of-lidocaine-adrenaline Summary • Xylocaine® 1% with adrenaline...
